2-Benzoxazolinone

We are 2-Benzoxazolinone CAS:59-49-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Benzoxazolinone
CAS.NO:59-49-4
Synonyms:2-Benzoxazolinone
3H-benzoxazol-2-one
Benzoxazolinone
2(3H)-Benzoxazolone
Benzoxazole-2-ol
2,3-dihydrobenzoxazol-2-one
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 299ºC at 760 mmHg
Melting Point 137-139 °C(lit.)
Molecular Formula C7H5NO2
Molecular Weight 135.120
Flash Point 160 °C
Index of Refraction 1.586
 
Specification:
Appearance:Brown-red powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Phosalone(CAS:2310-17-0) and Fenoxiapro-P-Ethyl(CAS:66441-23-4).

2-Benzoxazolinone


Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.(1R,3s,5S)-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.93-07-2 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.5-(2-Bromoethyl)-2,3-Dihydrobenzofuran The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.

Related Products
Product Name
5-chloro-2-fluoro-4-methylpyridine View Details
O-(5-Norbornene-2,3-dicarboximido)-N,N,N′,N′-tetramethyluronium tetrafluoroborate View Details
benzyl (2S)-2-amino-3-methylbutanoate,hydrochloride View Details
4-[6-amino-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile manufacturer 6-(chloromethyl)-11H-benzo[c][1]benzazepine manufacturer 9H-Purine-2,6-diamine, 9-.β.-D-ribofuranosyl- manufacturer N4-Acetylcytosine manufacturer tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate manufacturer